Receptor.AI
Healthcare AI
Drug discovery
Grant
Receptor.AI is a TechBio drug discovery company that uses a multi-platform AI ecosystem and modality-agnostic decision engine to help define therapeutic strategy and design molecules across small molecules, peptides, and induced-proximity therapeutics. The company says it focuses on more rational, evidence-driven therapeutic design and targets complex biology, with operations spanning the U.S., U.K., and Germany.
Company Details
- Website
- receptor.ai
- Headquarters
- Cambridge, Massachusetts, United States
- Founded
- 2021
- Funding
- Undisclosed
Subscriber Intelligence
- • Deal signal alerts for this company
- • Sentiment & risk scoring
- • Competitive framework analysis
- • Regulatory event monitoring